How can an opioid prescribing rate change when the unit is a visit instead of a patient?

Two denominators in the same shoulder-injury study

A retrospective study of acute rotator cuff tear encounters in a large health system identified 9,376 eligible visits involving 5,310 patients. At 1,559 visits, or 16.6%, clinicians issued at least one opioid or benzodiazepine prescription. At the patient level, 1,096 people, or 20.6%, received at least one of those prescriptions during the study period.

Why the percentages differ

A person could have several eligible visits. In the visit calculation, every encounter counts separately. In the patient calculation, a person who received a qualifying prescription at any visit counts once. The investigators also reported the total number of prescriptions, which can exceed the number of visits involving prescribing because a visit may generate more than one order.

What an injury record can establish

A charted prescription provides evidence of an order issued during care. To reconstruct exposure before a particular event, distinguish the prescription date from any dispensing record and from evidence of actual use. The study’s percentages describe prescribing within its participating system. They do not measure how many patients took the drug, and the combined endpoint should be quoted as opioid or benzodiazepine prescribing.

Source study

Read the full paper in PubMed Central (PMC8129054).

Spread the love


The National Black Lawyers

top 40 lawyers

civil trial law

Lawyers of Distinction

Loading...

Recent Blog Articles

When Low Sodium and Confusion Follow CBD Use During Sertraline Treatment

When confusion begins after a product change, a medication timeline and objective laboratory measurements can help organize competing explanations. A published case involved an individual who added CBD after years on sertraline and later developed low serum sodium and cognitive symptoms. The observation and the proposed mechanism The reported CYP2C19…

Spread the love

Read Article: When Low Sodium and Confusion Follow CBD Use During Sertraline Treatment

Can an AKT1 Test Explain an Individual’s Reaction to Cannabis?

A genetic association can help explain why responses differ across a group. To explain a particular person’s reaction, an expert still needs to connect the exposure, timing and recorded symptoms. Morgan and colleagues examined how AKT1 variation tracked with short-term symptoms after cannabis use. How the researchers measured acute response…

Spread the love

Read Article: Can an AKT1 Test Explain an Individual’s Reaction to Cannabis?

Can a Study of Self-Selected Cannabis Edibles Rank Their Cognitive Effects?

A study can observe meaningful differences across cannabis product groups even when the groups started out with different characteristics. Martin-Willett and colleagues measured cognition before and after edible use in adults with chronic, nonspecific low back pain. What the researchers compared The 183 participants self-selected CBD-dominant, THC-dominant or mixed products….

Spread the love

Read Article: Can a Study of Self-Selected Cannabis Edibles Rank Their Cognitive Effects?

Speak with an expert today!

Contact the offices of Okorie Okorocha for professional and reliable advice which you can trust.

Call (424) 363-3347 Contact Us